Ray Dalio
INSP icon

Ray Dalio’s Inspire Medical Systems INSP Stock Holding History

Ray Dalio’s Portfolio INSP Stock Details INSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-173,533
Closed -$8.95M – 1084
2026
Q1 		$8.95M Buy
173,533
+101,806
+142% +$7.13M 0.04% 283
2025
Q4 		$6.62M Sell
71,727
-17,225
-19% -$1.65M 0.02% 451
2025
Q3 		$6.6M Sell
88,952
-52,695
-37% -$5.34M 0.03% 423
2025
Q2 		$18.4M Buy
141,647
+68,796
+94% +$10M 0.07% 188
2025
Q1 		$11.6M Buy
72,851
+69,689
+2,204% +$12.6M 0.05% 237
2024
Q4 		$586K Sell
3,162
-1,378
-30% -$267K ﹤0.01% 569
2024
Q3 		$958K Sell
4,540
-752
-14% -$131K 0.01% 607
2024
Q2 		$708K Sell
5,292
-527
-9% -$100K ﹤0.01% 714
2024
Q1 		$1.25M Sell
5,819
-1,186
-17% -$232K 0.01% 550
2023
Q4 		$1.43M Sell
7,005
-28,196
-80% -$4.57M 0.01% 582
2023
Q3 		$6.99M Buy
35,201
+3,636
+12% +$917K 0.04% 294
2023
Q2 		$10.2M Sell
31,565
-3,594
-10% -$1.03M 0.06% 194
2023
Q1 		$8.23M Buy
35,159
+1,531
+5% +$387K 0.05% 229
2022
Q4 		$8.47M Sell
33,628
-11,225
-25% -$2.39M 0.05% 272
2022
Q3 		$7.96M Sell
44,853
-33,758
-43% -$6.78M 0.04% 296
2022
Q2 		$14.4M Buy
78,611
+4,209
+6% +$839K 0.06% 263
2022
Q1 		$19.1M Buy
74,402
+18,775
+34% +$4.29M 0.08% 190
2021
Q4 		$12.8M Buy
55,627
+8,207
+17% +$2M 0.07% 158
2021
Q3 		$11M Sell
47,420
-1,622
-3% -$338K 0.06% 193
2021
Q2 		$9.48M Buy
49,042
+45,929
+1,475% +$9.11M 0.06% 220
2021
Q1 		$644K Buy
+3,113
New +$662K 0.01% 354

Other funds holding INSP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Soleus Capital Management
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return
Deerfield Management
Deerfield Management New York $9.6B AUM 113.36% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Ray Dalio's INSP Position: Q2 2026 in Review

Ray Dalio sold out of Inspire Medical Systems (INSP) in Q2 2026, closing a stake of 173,533 shares — an estimated $8.95M sold.

Ray Dalio first reported a position in INSP in Q1 2021 and held it in 21 quarters. The position peaked at $19.1M in Q1 2022. 275 funds tracked by Wall St. Rank hold INSP as of Q2 2026.

  • Ray Dalio reported no remaining Inspire Medical Systems position as of Q2 2026 after selling out during the quarter.
  • Ray Dalio sold 173,533 Inspire Medical Systems shares in Q2 2026, an estimated $8.95M.
  • Ray Dalio first reported a position in Inspire Medical Systems in Q1 2021 and held it in 21 quarters.
  • Ray Dalio's Inspire Medical Systems position peaked at $19.1M in Q1 2022.
  • 275 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q2 2026.

Based on Bridgewater Associates's 13F filing for Q2 2026, filed 14 Aug 2026.